GlaxoSmithKline PLC Director/PDMR Shareholding (5148Q)
19 Febrero 2019 - 8:26AM
UK Regulatory
TIDMGSK
RNS Number : 5148Q
GlaxoSmithKline PLC
19 February 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==========================================================================================
a) Name Ms E Walmsley
==== ====================================== ==================================================
b) Position/status Chief Executive Officer
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Transfer of 102,035 Ordinary Shares between
transaction accounts for nil consideration.
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP0.00 102,035
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-18
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
==========================================================================================
a) Name Ms E Walmsley
==== ====================================== ==================================================
b) Position/status Chief Executive Officer
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Transfer of 102,035 Ordinary Shares to
transaction spouse for nil consideration.
No change in beneficial ownership.
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP0.00 102,035
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-18
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
Details of PDMR/person closely associated with them
('PCA')
==========================================================================================
a) Name Mr David Owen
==== ====================================== ==================================================
b) Position/status PCA of Ms E Walmsley (Chief Executive
Officer)
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Receipt of 102,035 Ordinary Shares from
transaction spouse for nil consideration.
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP0.00 102,035
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-18
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHZKLFFKLFLBBB
(END) Dow Jones Newswires
February 19, 2019 09:26 ET (14:26 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024